Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2289]
News [4632]
Articles [192]
Editorials [8]
Conferences [135]
elearning [9]
BRCA carrier status as a prognostic factor for prostate cancer
Dr Elena Castro - The Institute of Cancer Research, Sutton, UK
BRCA carrier status as a prognostic factor for prostate cancer ( Dr Elena Castro - The Institute of Cancer Research, Sutton, UK )
20 Jun 2012
Retrospective study of optimal treatment for intermediate-risk testes cancer
Dr Constantine Albany - Indiana University, Indianapolis, USA
Retrospective study of optimal treatment for intermediate-risk testes cancer ( Dr Constantine Albany - Indiana University, Indianapolis, USA )
20 Jun 2012
Open Window project improves patient quality of life
Dr Shaun McCann - St James's Hospital, Dublin, Ireland
Open Window project improves patient quality of life ( Dr Shaun McCann - St James's Hospital, Dublin, Ireland )
15 Jun 2012
Role of family history and genetic testing in diagnosis
Dr Marie Wood – University of Vermont, Burlington, USA
Role of family history and genetic testing in diagnosis ( Dr Marie Wood – University of Vermont, Burlington, USA )
15 Jun 2012
Regorafenib effective for GISTs that progress due to resistance to approved...
Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA )
13 Jun 2012
ASCO 2012: Advances in myeloma
Dr Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France; Prof...
ASCO 2012: Advances in myeloma ( Dr Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France; Prof Gareth Morgan - Royal Marsden Hospital, UK )
12 Jun 2012
Current treatment practices in metastatic castration resistant prostate cancer
Prof Joachim Bellmunt, Prof Nicolas Mottet, Prof Noel Clarke, Prof Alfredo...
Current treatment practices in metastatic castration resistant prostate cancer ( Prof Joachim Bellmunt, Prof Nicolas Mottet, Prof Noel Clarke, Prof Alfredo Berruti )
22 May 2012
Problems in the structure of clinical trials
Prof Thomas Tursz – Institut Gustave Roussy, Paris, France
Problems in the structure of clinical trials ( Prof Thomas Tursz – Institut Gustave Roussy, Paris, France )
21 May 2012
New approaches to personalised medicine
Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany
New approaches to personalised medicine ( Prof Jens Ricke – Otto-Von-Guericke-University, Magdeburg, Germany )
18 May 2012
Heterogeneity of tumours and the challenges of biomarker development
Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy
Heterogeneity of tumours and the challenges of biomarker development ( Prof Giuseppe Curigliano – European Institute of Oncology, Milan, Italy )
17 May 2012
Cancer genes differ in different parts of a tumour
Prof Charles Swanton - CRUK London Research Institute and UCL, UK
Cancer genes differ in different parts of a tumour ( Prof Charles Swanton - CRUK London Research Institute and UCL, UK )
17 May 2012
Targeting DNA damage response and repair excluding PARP for triple negative...
Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden
Targeting DNA damage response and repair excluding PARP for triple negative breast cancer ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )
17 May 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation